Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Preclinical Assessment
59%
Hepatocellular Carcinoma
56%
In Cancer
50%
Clinical Trials
49%
Liver Transplantation
40%
Toxicity Index
40%
Cancer Clinical Trials
35%
Confidence Interval
34%
Sex Differences
32%
Patient-reported Outcomes
28%
Acute Ischemic Stroke
28%
Overall Survival
27%
NSABP
26%
Multi-laboratory
25%
Patient-Reported Outcomes Measurement Information System (PROMIS)
24%
Whole Brain
24%
Autoimmune Hepatitis
24%
Tumor
24%
Heart Failure
23%
Plaque
23%
Ischemia
22%
Phase I Clinical Trial
21%
Single-photon Emission Computed Tomography (SPECT)
20%
Body Mass Index
19%
Adverse Events
19%
Colorectal Cancer
19%
Polymorphism
19%
Maximum Tolerated Dose
18%
Barcelona Clinic Liver Cancer
18%
Dose Combination
18%
Anastrozole
18%
Imaging Studies
17%
Response Criteria
17%
Continuous Dose
16%
Brain Vessels
16%
Hepatic Carcinoma
16%
HER3
16%
Randomized Clinical Trial
16%
Chloroquine
16%
NRG Oncology
16%
Atherosclerotic Lesions
16%
Index Patient
16%
Double-blind Randomized Trial
16%
Breast Cancer Survivors
16%
Inhibitory Control
16%
Bayesian Adaptive Design
16%
Weight Loss Program
16%
Preclinical Trials
16%
Graft-versus-host Disease (GvHD)
16%
Disease Intervention
16%
Medicine and Dentistry
Apoplexy
100%
Brain Ischemia
57%
Hepatocellular Carcinoma
43%
Diseases
35%
Breast Cancer
33%
Neoplasm
29%
Overall Survival
26%
Clinical Trial
23%
Randomized Controlled Trial
21%
Single-Photon Emission Computed Tomography
20%
Ischemia
18%
Treatment Response
18%
Malignant Neoplasm
17%
Tumor
17%
Cardiac Magnetic Resonance Imaging
16%
Autoimmune Hepatitis
16%
Nonalcoholic Fatty Liver
16%
Colorectal Carcinoma
16%
Liver Transplantation
16%
Acute Graft Versus Host Disease
16%
Sex Differences
16%
Oncology
16%
Odds Ratio
15%
Morphology
14%
Magnetic Resonance Imaging
14%
Prevalence
14%
Comorbidity
13%
Myocardial Perfusion Imaging
13%
Recurrent Disease
12%
Middle Cerebral Artery Occlusion
12%
Arm
12%
Computer Assisted Tomography
12%
Disease Free Survival
12%
Cohort Analysis
11%
Spontaneously Hypertensive Rat
11%
Hereditary Nonpolyposis Colorectal Cancer
11%
Major Adverse Cardiac Event
10%
Placebo
10%
Infection
10%
Liver Cirrhosis
10%
Hazard Ratio
10%
Medicine
10%
Patient-Reported Outcome
10%
Graft Versus Host Reaction
10%
Gamma Urogastrone
9%
Endothelial Dysfunction
9%
Congestive Heart Failure
9%
Rigor
9%
Prognostication
9%
Transcatheter Arterial Chemoembolization
8%